pH titration effects on the CD spectra of angiotensin II, truncated peptides and other analogues: aromatic region. 1975

K Lintner, and S Fermandjian, and P Fromageot

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D002942 Circular Dichroism A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Circular Dichroism, Vibrational,Dichroism, Circular,Vibrational Circular Dichroism
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

K Lintner, and S Fermandjian, and P Fromageot
January 1976, European journal of biochemistry,
K Lintner, and S Fermandjian, and P Fromageot
January 1968, Biochimica et biophysica acta,
K Lintner, and S Fermandjian, and P Fromageot
February 1974, Canadian journal of biochemistry,
K Lintner, and S Fermandjian, and P Fromageot
September 1981, Journal of medicinal chemistry,
K Lintner, and S Fermandjian, and P Fromageot
August 1994, British journal of clinical pharmacology,
K Lintner, and S Fermandjian, and P Fromageot
January 1984, Acta physiologica et pharmacologica Bulgarica,
K Lintner, and S Fermandjian, and P Fromageot
March 1975, The Journal of physiology,
K Lintner, and S Fermandjian, and P Fromageot
January 1967, New Istanbul contribution to clinical science,
K Lintner, and S Fermandjian, and P Fromageot
December 1972, Circulation research,
K Lintner, and S Fermandjian, and P Fromageot
January 2013, Current pharmaceutical design,
Copied contents to your clipboard!